↓ Skip to main content

Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1

Overview of attention for article published in Frontiers in oncology, April 2023
Altmetric Badge

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma via the combination therapy with FOXM1 inhibitor RCM1
Published in
Frontiers in oncology, April 2023
DOI 10.3389/fonc.2023.1163510
Pubmed ID
Authors

Johnny Donovan, Zicheng Deng, Fenghua Bian, Samriddhi Shukla, Jose Gomez-Arroyo, Donglu Shi, Vladimir V. Kalinichenko, Tanya V. Kalin

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 100%
Readers by discipline Count As %
Unspecified 1 100%